>
The Japanese Yen is at its lowest level since 1986 against the US Dollar, losing 54% of its value...
TINA PETERS: "JUST SAY YOU LIED." SHE REFUSED.
JUST IN: Wells Fargo, the $2.5 TRILLION Wall Street giant, just revealed...
Turkey's Erdo?an gives NATO leaders a handgun conundrum after summit
Modular Reactors To Solve Data Center Hysteria?
DeepSeek Developing In-House AI Chip In Bid To Cut Nvidia Reliance
America just took three brand-new nuclear reactors critical in thirty days, a first for any...
Your brain doesn't peak in your 20s after all: Study reveals your mind is at its sharpest betwee
Compasses, not maps: China is building a different type of AI
Farewell, atom-smashing Large Hadron Collider
It's Not a Conspiracy Anymore: Med Beds Exist and Trump Knows It

"Technocracy is the science of social engineering," says Patrick Wood, author of Technocracy Rising.
Social engineering used to mean molding the minds of people to conform to new norms. This goes back to 1928, Ed Bernays, and his book Propaganda. However, in a Technocracy, not only minds, but bodies, too, can be molded. If you did not get the memo, Technocracy has brought humanity from Human to Posthuman and Transhuman.
In the 2022 Journal Global Trends, Russian scientists describe the difference between Posthuman and Transhuman:
The fundamental idea of posthumanism is the rejection of biological, ethical, and ontological anthropocentrism. Transhumanism focuses on changing and improving natural human characteristics through biological, technological, and cognitive modifications…Transhumanism has the potential to preserve man as an effective economic and cognizing agent.
In other words, man as an "economic agent" refers to the cybernetic human as a commodity in a modern world. This means the laws of the nations need to change to catch up.
The U.S. FDA is meeting that goal for change with its FDA Modernization Act 2.0. What is the FDA Modernization Act 2.0?
The new law amends the Federal Food, Drug, and Cosmetic Act by authorizing sponsors of novel drugs to make use of "certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.